What is the appropriate management for a patient taking amlodipine 10 mg daily and metoprolol extended‑release 25 mg daily who has a blood pressure of 138/90 mmHg?

Management Recommendation

Add a thiazide or thiazide-like diuretic to the current regimen of amlodipine 10 mg and metoprolol XL 25 mg to achieve better blood pressure control.

Current Blood Pressure Status

Your patient's BP of 138/90 mmHg falls into the high-normal range (130-139/85-89 mmHg) according to the 2020 ISH guidelines 1. However, the 2024 ESC guidelines recommend a target BP of 120-129 mmHg systolic for most adults to reduce cardiovascular risk 2, and the 2025 AHA/ACC guidelines similarly target BP <130/80 mmHg 3. This patient is not at goal.

Why the Current Regimen is Suboptimal

The patient is already on:

• Amlodipine 10 mg (maximum dose of a dihydropyridine calcium channel blocker)
• Metoprolol XL 25 mg (a low dose beta-blocker)

Beta-blockers are not first-line agents for uncomplicated hypertension according to current guidelines. The 2020 ISH guidelines clearly state that beta-blockers should be added only as a fourth-line agent after ACE inhibitors/ARBs, calcium channel blockers, and thiazide diuretics have been tried 1. The 2024 ESC guidelines similarly recommend beta-blockers only when there are compelling indications such as angina, post-MI, heart failure with reduced ejection fraction, or for heart rate control 2.

Recommended Treatment Algorithm

Step 1: Assess for Compelling Indications

• Does the patient have coronary artery disease, prior MI, heart failure, or atrial fibrillation requiring rate control?
• If YES: Continue metoprolol and proceed to Step 2
• If NO: Consider replacing metoprolol with an ACE inhibitor or ARB

Step 2: Add Third-Line Agent

Since amlodipine is already at maximum dose (10 mg), add a thiazide or thiazide-like diuretic as the next step 1, 3, 2:

• Chlorthalidone 12.5-25 mg daily, OR
• Indapamide 1.25-2.5 mg daily, OR
• Hydrochlorothiazide 12.5-25 mg daily

The 2020 ISH guidelines specifically recommend this three-drug combination: RAS blocker (or in this case, continue current regimen) + calcium channel blocker + thiazide diuretic, preferably as a single-pill combination 1.

Step 3: Consider Optimizing the Beta-Blocker

If metoprolol is being continued for a compelling indication, the current dose of 25 mg XL is quite low. The FDA label indicates typical dosing ranges from 25-200 mg daily for hypertension 4. However, increasing metoprolol dose should be secondary to adding the diuretic, as beta-blockers have less robust cardiovascular outcome data in uncomplicated hypertension.

Important Caveats

Before adding a diuretic, check:

• Baseline electrolytes (potassium, sodium, magnesium)
• Renal function (creatinine, eGFR)
• Uric acid levels (if gout history)
• Volume status

Monitor for:

• Hypokalemia (most common with thiazides)
• Hyperglycemia (thiazides can worsen glucose control)
• Hyperuricemia
• Orthostatic hypotension, especially in elderly patients

Medication adherence should be verified before escalating therapy. The 2020 ISH guidelines emphasize checking adherence as a key step 1. Consider once-daily dosing and single-pill combinations to improve adherence 1, 2.

Alternative Consideration: Replace Metoprolol

If the patient has no compelling indication for beta-blocker therapy, a more guideline-concordant approach would be:

1. Discontinue metoprolol XL 25 mg
2. Add an ACE inhibitor or ARB (e.g., lisinopril 10-20 mg daily, losartan 50-100 mg daily)
3. This creates the preferred combination: ACE inhibitor/ARB + calcium channel blocker + thiazide diuretic 1, 3, 2

This three-drug combination is the standard recommended regimen for patients requiring triple therapy in all major guidelines 1, 3, 2.

Timeline for Reassessment

• Recheck BP in 2-4 weeks after medication adjustment
• Target achievement should occur within 3 months 1, 2
• If BP remains uncontrolled on three agents, consider adding spironolactone 25-50 mg daily as a fourth-line agent 1, 2